A meeting of minds: Overcoming roadblocks in the development of therapies for neurodegenerative disorders
β Scribed by Miratul M. K. Muqit; Dario R. Alessi
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 108 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1757-4676
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Competitive exclusion treatment is able to increase the pathogen colonization resistance of dayβold chicks by applying probiotic bacteria stabilizing the indigenous microflora. In order to develop a safe microbial feed additive, various bacterial strains were isolated out of the gastroi
## Abstract ## Background Geneβdirected enzyme prodrug therapy (GDEPT) based on the __E. coli__ enzyme purine nucleoside phosphorylase (PNP) represents a new approach for treating slow growing tumours like prostate cancer (PCa). Expressed enzyme converts a systemically administered prodrug, fludar
The congenital disorders of glycosylation (CDG) are a group of diseases caused by genetic defects affecting N-glycosylation. The most prevalent form of CDG-type Ia-is caused by defects in the PMM2 gene. This work reports the study of two new nucleotide changes (c.256-1G>C and c.640-9T>G) identified